Tobira Therapeutics

develops and commercializes therapies to treat non-alcoholic steatohepatitis, liver diseases, inflammation, fibrosis and HIV...
Read more
Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
1-25
Agree?
Funding
$75M

News

Feb 19, 2018
BioPortfolio
Tobira Therapeutics: Tobira Therapeutics Inc TBRA Medical Equipment Deals and Alliances Profile Report Updated 09022018 Prices from USD $250
Jan 04, 2018
BioPortfolio
Tobira Therapeutics: Tobira Therapeutics Inc TBRA Medical Equipment Deals and Alliances Profile Report Updated 21122017 Prices from USD $250
Oct 12, 2017
BioPortfolio
Tobira Therapeutics: Tobira Therapeutics Inc TBRA Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 14092017 Prices from USD $250
May 25, 2017
BioPortfolio
Tobira Therapeutics: Tobira Therapeutics Inc TBRA Pharmaceuticals Healthcare Deals and Alliances Profile Updated 17052017 Prices from USD $250
Mar 29, 2017
BioPortfolio
Tobira Therapeutics: Tobira Therapeutics Inc TBRA Pharmaceuticals Healthcare Deals and Alliances Profile Updated 24022017 Prices from USD $250
Feb 28, 2017
BioPortfolio
Tobira Therapeutics: Tobira Therapeutics Inc TBRA Medical Equipment Deals and Alliances Profile Updated 25012017 Prices from USD $250
Jan 20, 2017
BioPortfolio
Tobira Therapeutics: Tobira Therapeutics Inc TBRA Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250
Jan 06, 2017
BioPortfolio
Tobira Therapeutics: Tobira Therapeutics Inc TBRA Medical Equipment Deals and Alliances Profile Prices from USD $250
Dec 03, 2016
Insider Monkey
Tobira Therapeutics: Is Tobira Therapeutics Inc (TBRA) A Good Stock To Buy?
Nov 17, 2016
BioPortfolio
Tobira Therapeutics: Tobira Therapeutics Inc. TBRA Financial and Strategic SWOT Analysis Review Prices from USD $300

Tobira Therapeutics Competitors

1Madrigal
2Metacrine
3Nimbus Therapeutics
4PhaseBio
5Esperion
6Intercept
7Gilead Sciences
8DICE
9Galectin
10Gossamer Bio

Trending Companies